Safety of COVID-19 vaccines
Supporting Files
Public Domain
-
April 13, 2021
File Language:
English
Details
-
Corporate Authors:
-
Description:Updated Apr. 13, 2021
Johnson & Johnson’s Janssen COVID-19 Vaccine: CDC and FDA have recommended a pause in the use of Johnson & Johnson’s J&J/Janssen COVID-19 Vaccine in the United States out of an abundance of caution, effective Tuesday, April 13. The Advisory Committee on Immunization Practices (ACIP) will hold its second emergency meeting to discuss J&J/Janssen COVID-19 Vaccine on April 23, 2021. People who have received the J&J/Janssen COVID-19 Vaccine within the past three weeks who develop severe headache, abdominal pain, leg pain, or shortness of breath should seek medical care right away.
-
Content Notes:What CDC is doing -- Establishing a vaccine breakthrough case definition -- Identifying and investigating COVID-19 vaccine breakthrough cases -- Developing a data access and management system for COVID-19 vaccine breakthrough cases -- COVID-19 vaccine breakthrough infections reported to CDC -- How to interpret these data -- COVID-19 Vaccines are Effective.
-
Subjects:
-
Document Type:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:urn:sha256:a84de6061daaf558ad866b4bf8e1877da378caf5ef23f27b213c6a412e746b83
-
Download URL:
-
File Type:
Supporting Files
-
html
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Stephen B. Thacker CDC Library